Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
People channel feed
Kojin Therapeutics shuts down, citing lack of investor interest and complex science
3 months ago
Startups
Updated: Kennedy is confirmed to lead HHS, putting anti-vaccine advocate and drug industry skeptic atop US health programs
3 months ago
Pharma
Neumora shakes up C-suite a month after depression drug fails first Phase 3 trial
3 months ago
New CMO Dietmar Berger highlights Gilead’s ‘unique situation’ and its HIV ambitions
3 months ago
R&D
Pharma
Inventiva cuts pipeline, lays off nearly entire research team in bid to get to Phase 3 MASH readout
3 months ago
R&D
Vertex operations chief Stuart Arbuckle to retire
3 months ago
Pharma
Major FDA staff cuts would slow drug reviews, experts say
3 months ago
FDA+
Updated: Bay Area biotech VC to shut down 15 months after launch, sources say, after key investor pulls out
3 months ago
Financing
Pfizer hires Novartis oncology exec to steer its cancer ambitions
3 months ago
Pharma
Updated: RFK Jr. advances out of Senate committee with Cassidy’s support
3 months ago
FDA+
Astellas shakes up management despite impressive nine-month earnings
3 months ago
Pharma
Flagship spinout Omega is days away from bankruptcy, filing shows
3 months ago
Startups
Exclusive: Noom cuts coaches and customer service staff as fewer sign up
3 months ago
Health Tech
Charles River to shut down North Carolina pathology facility, says it's not a 'strategic fit'
3 months ago
Outsourcing
Manufacturing
Thermo Fisher to lay off 300 workers at two viral vector factories
3 months ago
Cell/Gene Tx
Manufacturing
RFK Jr. evades questions on vaccines and autism in written responses to senators
3 months ago
FDA+
Daiichi Sankyo taps new CEO, aims to build up ADC franchise
3 months ago
R&D
Rentschler exits cell and gene business due to low demand, will prioritize biologics
3 months ago
Manufacturing
Cargo Therapeutics cuts lead CAR-T program, 50% of staff
3 months ago
R&D
Cell/Gene Tx
Takeda CEO Christophe Weber to retire in June 2026, Julie Kim to take over
3 months ago
Pharma
Key GOP senator is ‘struggling’ with Kennedy nomination over vaccine answers
3 months ago
Pharma
FDA+
Updated: Zentalis lays off 40% of staff, whittles down indications for WEE1 inhibitor
3 months ago
The RFK question: Trump's HHS nominee splits biopharma before moment of truth
3 months ago
FDA+
Updated: Cell therapy biotech Affini-T Therapeutics reduces staff
3 months ago
Cell/Gene Tx
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page
